FDA approves Mounjaro, a new drug taken once a week to treat type 2 diabetes

The US Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes (T2D), as an adjunct to diet and exercise . The drug, made by Eli Lilly, improved blood sugar levels more effectively than other diabetes therapies that were included in the clinical trials that …

FDA approves Mounjaro, a new drug taken once a week to treat type 2 diabetes Read More »